Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes
COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has produced a serious emergency for global public health, placing enormous stress on national health systems in many countries. Several studies suggest that cytokine storms (interleukins) may play an important role in severe cases of C...
Saved in:
Main Authors: | Natalia Navas (Author), Jesús Hermosilla (Author), Anabel Torrente-López (Author), José Hernández-Jiménez (Author), Jose Cabeza (Author), Raquel Pérez-Robles (Author), Antonio Salmerón-García (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding
by: Alicia Torres-García, et al.
Published: (2024) -
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress
by: Anabel Torrente-López, et al.
Published: (2022) -
Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis
by: A. Lo Gullo, et al.
Published: (2017) -
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report
by: Francesca Burlo, et al.
Published: (2023) -
Drug shortages in Israel: regulatory perspectives, challenges and solutions
by: Eyal Schwartzberg, et al.
Published: (2017)